Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision to Use Roche s AmpliChip CYP450 Test

NEW YORK, Nov. 3 (GenomeWeb News) - DNAVision will begin service of Roche Diagnostics' AmpliChip CYP450 test, the company said today.


The AmpliChip CYP450, which is built upon the Affymetrix microarray platform, analyzes the cytochrome P450 2D6 and 2C19 genotypes to help determine the appropriate dosages of medications for a variety of conditions, including pain medication, cardiac disease, cancer, and depression.


"DNAVision is proud to be chosen by Roche Diagnostics Belgium as the first European pharmacogenomic private testing laboratory to provide this first FDA approved DNA microarray test" said Arnaud Termonia, scientific advisor of DNAVision, in a statement.


The U.S. Food and Drug Administration cleared the AmpliChip CYP450 test for diagnostic use earlier this year.





The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.